A Retrospective study of consecutive patients treated with BioMimea Sirolimus Eluting Coronary Stent System during a pre-defined period. - MeriT-lll A
Latest Information Update: 15 Jun 2020
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Adverse reactions
- Sponsors Meril Life Sciences
- 15 Dec 2017 New trial record